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Retinoic acid has long been known to alter skin and hair growth but an exact mechanism is unclear. This study was
performed to examine the sites of endogenous retinoic acid synthesis in the cycling hair follicle to better
understand the role retinoic acid plays in this process. Retinal dehydrogenases (Aldh1a1, 2, and 3, formerly Raldh
1, 2, and 3) are the enzymes responsible for the last step in retinoic acid synthesis. Immunohistochemistry was
performed on adult C57BL/6J mouse skin sections with antibodies against Aldh1a2 and Aldh1a3. Aldh1a2
expression was seen primarily in the outer root sheath and basal/spinous layer during all stages of the hair cycle,
and in the bulge during anagen and early catagen, whereas Aldh1a3 expression was primarily in the dermal papilla,
pre-cortex, and hair shaft during mid–late anagen. The expression patterns of these two similar retinoic acid
synthesizing enzymes at speciﬁc follicular sites suggest that they mediate and are regulated by different epithelial
proliferation and differentiation signaling pathways.
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Vitamin A and its derivatives (retinoids) are critically
important in the development and maintenance of multiple
tissues, including skin and hair, as shown by the detrimental
effects of vitamin A deficiency (Wolbach and Howe, 1925;
Frazier and Hu, 1931). These observations have led to the
widespread use of retinoids in various skin disorders
(Stuttgen, 1986). All-trans retinoic acid (atRA) was proven
in vivo (Werner and DeLuca, 2001) and in vitro (Kurlandsky
et al, 1994) to be the most physiologically relevant retinoid in
the skin. But, due to toxicity issues, 13-cis retinoic acid
(13cRA, i.e., Accutane, Roche Laboratories, Inc., Nutley,
New Jersey), which can slowly isomerize to atRA, is used
more frequently in clinically abnormal states (Stuttgen, 1986).
The regulation of endogenous atRA synthesis and its
precise tissue/cellular localization is a subject of active
investigation. AtRA was shown to be synthesized in cultured
keratinocytes (Kurlandsky et al, 1994) and degraded in
dermal fibroblasts (Randolph and Simon, 1998). This
degradation of atRA by the dermal fibroblasts would limit
the delivery of physiological concentrations of plasma atRA
to the epidermis and hair follicle making local atRA
synthesis essential for normal function. The synthesis of
atRA from circulating retinol occurs by the action of two
enzyme families (Napoli, 1999). Retinol dehydrogenases
(Rdh) convert retinol to retinal, whereas retinal dehydro-
genases (Aldh1a) convert retinal to RA. Two human
epidermal Rdh family members, hRODH-E and hRODH-
E2, have been identified (Jurukovski et al, 1999; Markova
et al, 2003). Currently, there are three known Aldh1a (1–3)
that convert all-trans retinal to atRA. Recent studies with
Aldh1a1 null mice suggest that this enzyme is involved in
the catabolism of excess retinol (Fan et al, 2003). The
expressions of the cellular retinol binding protein and
cellular retinoic acid binding protein type II have also been
associated with the ability to make RA (i.e., Bucco et al,
1997; Napoli, 1999). Therefore, expression of these binding
proteins and enzymes can be used as markers for sites of
RA synthesis.
Recently, Markova et al (2003) showed that hRODH-E2
transcripts are expressed in sebaceous and sweat glands,
matrix cells, and the Huxley cells of the inner root sheath
(IRS) of the infundibulum. But little data are available on the
expression pattern of Aldh1a in the hair follicle and
sebaceous gland. Most of the studies with Aldh1a2 and
Aldh1a3 have focused on embryogenesis. The temporal
and spatial expression patterns of retinal dehydrogenases
have been used as an initial step in dissecting the sites of
RA synthesis in the mouse embryo, the regulation of RA
synthesis, and the precise role of RA during embryonic
development. The expression of Aldh1a2 and Aldh1a3 is seen
at distinct times and locations throughout embryogenesis
The mouse genome nomenclature was used (www.informatics.
jax.org). Genes and RNA message expression is italicized, while
proteins are not. First letter capitalized followed by lowercase
indicates a mouse or rat gene, while all capital letters indicates the
human gene or protein.
Abbreviations: Aldh1a, retinal dehydrogenase; atRA, all-trans
retinoic acid; 13cRA, 13-cis retinoic acid; ILORS, inner layer of
the outer root sheath; IRS, inner root sheath; Lef/Tcf, lymphoid
enhancer factor/T-cell factor; ORS, outer root sheath; Rara,b,c,
retinoic acid receptor a, b, g; RA, retinoic acid; Shh, sonic
hedgehog; Wnt, wingless related MMTV
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(Blentic et al, 2003). In the developing hair follicle Aldh1a3
expression was reported at the base of the hair follicle at
5 d, but not 3 wk, post-partum (Niederreither et al, 2002a).
The sites of RA synthesis suggested in these expression
studies were consistent with developmental problems in
the null mice. Aldh1a2/ mice die in utero due to defects
in heart development (Niederreither et al, 1999), and
Aldh1a3/ mice die within 10 h of birth due to defects in
nasal development (Dupe et al, 2003). These defects can be
only partially restored with maternal RA administration,
suggesting that precise timing of RA synthesis at specific
sites is essential. Neither Aldh1a2 nor Aldh1a3 expression
patterns in the sebaceous gland or hair follicle have been
well described in the adult mammal. Thus, this report
describes the expression pattern of Aldh1a2 and Aldh1a3 in
the adult mouse hair follicle, as an initial step in dissecting
the role of endogenous RA in mammalian hair cycling.
Results and Discussion
To examine the possible sites of RA synthesis, immunohis-
tochemistry was performed on adult C57BL/6J mouse skin
with antibodies against Aldh1a2 and Aldh1a3. Dot blot
analysis of these antibodies against recombinant proteins
shows that these antibodies are specific (Fig 1). The anti-
Aldh1a2 antibody did not cross-react with Aldh1a3. There
was a slight cross-reaction of the anti-Aldh1a3 antibody
with Aldh1a2, but this antibody showed a 64-fold selectivity
for Aldh1a3 over Aldh1a2. Very different anatomical sites
of Aldh1a2 versus Aldh1a3 expression were observed in
mouse hair follicles and their associated sebaceous gland
at various stages in the hair cycle (Tables I and II and Figs 2
and 3). Each follicular site reflects a specific function in the
regulation of proliferation and differentiation during the hair
cycle. This differential localization of two proteins with the
Figure1
Dot blot analysis of antibodies against recombinant whole
proteins. Recombinant rat proteins Aldh1a2 (2) and Aldh1a3 (3) (0–25
pmol) were blotted onto nitrocellulose membranes, cut into strips, and
exposed to affinity-purified antibodies against Aldh1a2 (a) or Aldh1a3
(b). Detection was by enhanced chemiluminescence. The image shows
the two films for the two antibodies overlaying the strips of dot blotted
protein.
Table I. Aldh1a2 expression in the stages of the hair cyclea
Stage Basal Spin. Seb. ORS Bulge Prol. Ker. ILORS/CL ES Germ Caps.
Telogen þ þ þ  þ þ þ þ / NA NA NA þ þ þ
Anagen I þ þ þ / þ þ þ þ þ þ NA NA NA
Anagen II þ þ þ þ þ þ þ þ NA NA NA
Anagen IIIa þ þ þ þ þ þ þ þ þ NA NA NA
Anagen IIIb þ þ þ / þ þ in þ þ þ þ þ þ NA NA
Anagen IIIc þ þ þ / þ þ is þ þ NA þ þ NA NA
Anagen IV þ þ þ / þ þ is,in þ þ NA þ þ NA NA
Anagen V þ þ þ / þþ þ þ bin þ þ þ NA þ þ NA NA
Anagen VI/catagen I þ þ / 0þ bin þ þ NA þ / NA NA
Catagen II þ þ  0þ þ bin þ þ NA þ NA NA
Catagen III þ þ  0þ þ bin þ þ NA þ þ NA NA
Catagen IV þ þ / 0þ þ bin þ þ NA þ þ NA NA
Catagen V þ þ þ / þ þ þ þ / NA þ þ þ þ
Catagen VI þ þ þ / þ þ þ þ / NA þ þ þ þ
Catagen VII þ þ  þ þ þ þ / NA NA þ þ þ þ
Catagen VIII þ þ þ / þ þ þ þ / NA NA NA þ þ
aNegative (), faint (þ /), weak (þ ), strong (þ þ ), and very strong (þ þ þ ) staining is indicated. Basal/Spin, basal/spinous layer; Seb., sebocyte;
ORS, outer root sheath; Prol. Ker, proliferating keratinocyte strand between dermal papilla and club hair in early anagen; ILORS/CL, inner layer of the
outer root sheath/companion layer; ES, epithelial strand; Germ Caps., germ capsule; in, infundibulum; is, isthmus; b, bulb; NA, not applicable.
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apparent same enzymatic function allows RA signaling to
be differentially regulated at each unique site.
Dermal papilla: induction and termination of anagen,
catagen, and telogen There are three main stages of
the hair cycle: anagen (growth); catagen (regression); and
telogen (rest). Aldh1a2 was expressed strongly during all
stages of the hair cycle (Fig 2), whereas Aldh1a3 was
expressed primarily during mid–late anagen (Fig 3). During
telogen, Aldh1a2 was expressed strongly in the outer root
sheath (ORS), bulge and germ capsule (Table I, Fig 2a, and
inset i). In early anagen (I–IIIb) Aldh1a2 was expressed in the
Table II. Aldh1a3 expression in the stages of the hair cyclea
Stage Seb gland Seb duct ILORS/CL Hair Fiber Pre cortex DP Germ Caps.
Telogen  þ /   NA  
Anagen I  þþ þ NA NA NA þ / NA
Anagen II þ þþ þ NA NA NA  NA
Anagen IIIa þ þ NA    NA
IIIa–b þ þ NA  þ þ þ þ NA
Anagen IIIb    þ þ þ þ  NA
Anagen IIIc    þ þ þþ þ þ þ NA
Anagen IV   þ þ þ þ þ0 b–in þ þ þ NA
Anagen V    þ þ þ0 bin þ þ þ þ NA
Anagen VI/catagen I   þ þ þ þ0 bin þ þ þ þ / NA
Catagen II    þ þ þ0 bin þ þ  NA
Catagen III   þ þ / 0 bin   NA
Catagen IV   þ þ / 0 bin NA  NA
Catagen V  þ þ þ  NA  þ
Catagen VI þ / þ þ þ  NA  þ
Catagen VII þ /  NA  NA  þ
Catagen VIII þ /  NA  NA  
aNegative (), faint (þ /), weak (þ ), strong (þ þ ), and very strong (þ þ þ ) staining is indicated. Seb., sebocyte; ILORS/CL, inner layer of the outer
root sheath/companion layer; Hair fiber (aka shaft); Precortex, cells just above the matrix; DP, dermal papilla; Germ Caps., germ capsule; in,
infundibulum; b, bulb; NA, not applicable.
Figure 2
Aldh1a2 expression in adult mouse hair follicles. Immunohistochemical localization of Aldh1a2 in adult mouse hair follicles during telogen (a),
anagen IIIa (b), anagen V (c), catagen V (d), and catagen VII (e). Bar¼ 1 mm. Insets are higher magnifications of their respective follicles (arrows).
Bar¼ 0.1 mm all insets.
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bulge region and the proliferating keratinocytes between
the club hair and the bulb region (Table I, Fig 2b, inset iii).
Starting in mid-anagen, Aldh1a3 but not Aldh1a2 was
expressed in the bulb region (Table II, Figs 2b and c, 3a–e,
and Fig 3 insets ii, iv, v, vii–x and data not shown). This
Aldh1a3 expression appeared to differ during the stages of
anagen. In anagen IIIa–b, IIIc, and V Aldh1a3 localized to the
dermal papilla, but then in anagen IIIa–b, IIIb, IIIc, and VI it
was strongly expressed and anagen IV and V weakly
expressed in the pre-cortical region (Table II, Fig 3a–e and
inset ii, iv, v, vii–x and data not shown). The hair fiber (aka
shaft) expressed Aldh1a3 beginning in anagen IIIb and
increased in intensity through catagen II, then reduced its
intensity in catagen III and IV as hair growth ceases (Table II,
Fig 3c–e, insets v, viii, x, and data not shown). During late
anagen a gradient of Aldh1a3 expression is seen in the fiber
with the strongest expression seen in the pre-cortex region
and progressively weaker expression is seen as the fiber
reaches the skin surface (Fig 3e, insets x and xi). As was
seen for telogen and early anagen, the bulge region
continues to express Aldh1a2 throughout anagen (Table I,
Fig 2c, inset v). In addition, the ORS expression of Aldh1a2
is strongest in the isthmus near the bulge throughout
anagen, with a peak in expression seen during anagen V
and a drop at anagen VI/catagen I (Table I, Fig 2c, inset v
and data not shown). These expression patterns suggest
that Aldh1a2 may be involved in the pathways responsible
for overall maintenance of the hair follicle, whereas Aldh1a3
may be a positive regulator of anagen growth, through
epithelial–mesenchymal interactions.
The hair cycle is regulated through the interactions of
growth factors between the bulge area stem cells, the
dermal papilla, the epithelial matrix and pre-cortical cells
(reviewed in Stenn and Paus, 2001). All of these sites
expressed either Aldh1a2 or Aldh1a3 at some stage of the
hair cycle, suggesting a role of RA in these regulatory
pathways. Two of these growth factor signaling systems,
wingless related MMTV (Wnt) and sonic hedgehog (Shh),
are regulated by RA in other systems (Easwaran et al, 1999;
Power et al, 1999; Niederreither et al, 2002b), providing
further support for a possible role of RA in hair cycle
regulation. The localization of Aldh1a2 was consistent with
that of the Wnt transcription factor T cell factor 3 (Tcf3) in the
ORS and bulge, and the Shh receptor Ptc1 in the
proliferating keratinocytes between the DP and club hair
during early anagen and ORS in late anagen (Callahan and
Oro, 2001; Alonso and Fuchs, 2003; Oro and Higgins, 2003).
The expression of Aldh1a3 was similar to that of the Wnt
transcription factor lymphoid enhancer factor 1 (Lef1) in the
dermal papilla and pre-cortical cells, and Ptc 1 in the dermal
papilla. Tcf3 and Lef1 are in the same family of transcription
factors and it has been suggested that Tcf3 acts to inhibit
transcription in the bulge during Wnt stimulation, whereas
Lef1 activates transcription in the pre-cortex when stimu-
lated by Wnt. This differential expression of Aldh1a and Lef/
TcF family members at different sites within the hair follicle
would allow for site-specific regulation. Future studies could
examine whether RA has different effects on Lef1 versus
TcF3. In addition, do either Lef1 or TcF3 regulate Aldh1a2 or
Aldh1a3? A role for RA in stem cell regulation was first
noted by Wolbach and Howe in 1925. The expression of
Aldh1a2 in the bulge region throughout anagen (Table I, Fig
2b and c, insets iii and v) provides further support for such a
role of RA in stem cell maintenance.
During all stages of catagen, Aldh1a2 expression occurs
in the ORS, especially near the bulge (Table I, Fig 2d and e,
insets vii and viii). But the outer cells of the bulge do not
express Aldh1a2 in catagen V–VIII (Table I, Fig 2d and e,
insets vii and viii). Aldh1a2 also localizes to the germ
capsule cells as they form in catagen V–telogen (Table I, Fig
2a, d, and e, inset vi). Weak expression of Aldh1a3 was also
seen in the germ capsule during late catagen (Table II, data
Figure 3
Aldh1a3 expression in adult mouse hair follicles. Immunohistochemical localization of Aldh1a3 in adult mouse hair follicles during anagen IIIa (a),
IIIa–b (b), IIIc (c), V (d), and early VI (e). Bar¼ 1 mm. Insets are higher magnifications of their respective follicles (small arrows). Bar¼ 0.1 mm all insets.
Large arrows point to the sebaceous gland duct.
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not shown). The epithelial strand also showed Aldh1a2
expression during catagen V–VII (Table I, Fig 2d and e). In
the bulbar region Aldh1a3 expression is reduced as catagen
progresses (Table II, data not shown). The dermal papilla
only faintly expresses Aldh1a3 in anagen VI/catagen I (Fig
3e, inset ix) and is completely negative through catagen and
telogen. The pre-cortex ceases to express Aldh1a3 by
catagen III when these cells regress. Catagen is marked by
an arrest of proliferation in the bulbar region and massive
apoptosis (Stenn and Paus, 2001). Thus, loss of Aldh1a3
produced RA in the dermal papilla and Aldh1a2 produced
RA in the bulge may be involved in this arrest in proliferation.
In addition, added RA has been found to initiate apoptosis
in differentiating non-tumorogenic mouse keratinocytes
(Islam et al, 2000). The strong expression of Aldh1a2 within
the regressing catagen hair follicle suggests that RA
synthesis is involved in this catagen-induced apoptosis.
To confirm this, future studies with Tunel, Caspase 3 double
labeling on frozen sections can be done.
Sheath–ﬁber interactions The inner layer of the outer root
sheath (ILORS, aka companion layer) expressed Aldh1a2
strongly during anagen IIIb–V and catagen IV–VI, but weakly
during anagen VI–catagen III (Table I, Fig 2c, inset iv).
Aldh1a3 localized to the ILORS during anagen IV, anagen VI,
and catagen III–VI (Table II, data not shown). The ORS
expressed Aldh1a2 during all stages of the hair cycle with
the strongest expression in anagen V in the isthmus and
catagen V–telogen the whole length of the follicle (Table I,
Fig 2a, c, and e, insets i, v–viii). After anagen initiation
occurs, the newly made IRS and fiber must traverse the
ORS to move to the skin surface (Stenn and Paus, 2001).
This is thought to involve a proteolytic processs and the
expression of the tissue inhibitor of metalloproteinases
(TIMP) in Henle’s layer of the IRS and plasminogen activator
inhibitor-2 (PAI-2) in the ILORS. The expression of Aldh1a3
in the ILORS suggests a role for RA in this process. This
hypothesis is supported by recent microarray data in our
laboratory that found both TIMP and PAI-2 to be upregu-
lated by RA in the rat uterus (Li and Ong, unpublished
observation).
The sebaceous glands expressed both Aldh1a2 and
Aldh1a3 during anagen II–IIIa (Tables I and II, Fig 2b, inset iii,
Fig 3a and b, insets i, iii). There was light color in the
sebaceous glands at other times, but that may be non-
specific as a light background was sometimes noted (Fig
3c, inset vi). Aldh1a3 also localized to cells lining the
sebaceous gland duct during anagen I–IIIa and catagen V–
telogen (Table II, Fig 3a and b, insets i and iii large arrow,
and data not shown). Thus, RA synthesis may occur within
the sebocyte or in the isthmus where the sebaceous gland
duct opens and affect sebaceous gland function. In vitro
studies have shown that a factor produced by the
sebaceous gland, duct, or associated isthmus is required
for the hair fiber to be released from the IRS (Williams and
Stenn, 1994; Williams et al, 1996). These studies have been
supported in vivo by studies with the asebia mouse, which
have small, hypoplastic sebaceous glands, defects in the
release of the hair fiber, and progressive scarring alopecia
(Sundberg et al, 2000). RA has been shown to be important
for sebaceous gland function and hair sheath–fiber interac-
tions in a concentration-dependent manner (Zouboulis et al,
1993; Williams et al, 1996). Vitamin A deficiency in cultured
human sebocytes results in decreased cell proliferation and
lipogenesis that can be partially restored with low doses of
13cRA. At concentrations above 107 M 13cRA and atRA
inhibit proliferation, lipogenesis, and sheath growth (Zou-
boulis et al, 1993; Williams et al, 1996). The localization of
Aldh1a3 to sites just proximal to the sebaceous gland duct
and Aldh1a2 and Aldh1a3 within the sebocyte suggests that
RA made at these sites are important for sebocyte function
and the normal growth and release of the hair fiber.
Interfollicular epidermis and presumptive water barrier
Lipids made within the sebocyte are also essential for water
barrier formation (Madison, 2003). Thus, Aldh1a3 synthe-
sized RA may play a role in water barrier formation by altering
lipid metabolism in the sebocyte. This role of RA in sebocytes
is supported by studies of dominant negative Rara trans-
genic mice, which have defects in water barrier formation
and lipid metabolism (Attar et al, 1997). Also, RA has been
found to activate PPAR b/d (Shaw et al, 2003), whereas the
drug, clofibrate, has been found to increase barrier function
(Hanley et al, 1999). Aldh1a2 is localized to the ORS of the
infundibulum in all stages (Table I, Fig 2a–e, inset ii). But
Aldh1a3 was not seen in the ORS of the infundibulum at any
stage of the hair cycle (Fig 3a–e, data not shown). The
expression of Aldh1a2 within the basal/spinous layers
suggested that RA is also involved in differentiation in these
cells directly and not just in sebocyte lipid production. The
fact that RA synthesis at these two sites involved in water
barrier formation occurs by two separate enzymes suggests
that they are differentially regulated.
This report demonstrates that Aldh1a2 and Aldh1a3 are
expressed at different sites within the cycling hair follicle.
Their expression patterns suggest that locally produced RA
is important in all stages of the mammalian hair cycle.
Aldh1a3 expression may be involved in epithelial–mesench-
ymal interactions, whereas Aldh1a2 expression may be
involved in stem cell maintenance. Having different RA
synthesizing enzymes involved at each site and stage allow
differential regulation of each step in the hair cycle. Future
experiments will examine more closely the regulation of
these enzymes, as well as other components of RA
synthesis, during the normal hair cycle. Aldh1a expression
patterns in mice null for Wnts and Shh will help to establish
regulatory pathways in normal and abnormal skin and hair
growth.
Materials and Methods
Tissue acquisition Archived paraffin blocks of wax stripped
dorsal skin (used from previous hair cycle studies) from C57BL/
6J wild-type mice fixed with Tellyzneski–Fekete’s acid–alcohol–
formalin fixative were sectioned at 6 mm. The Paus system of
determining the stages of the hair cycle was used without
additional staining (Muller-Rover et al, 2001).
Antibodies Rabbit polyclonal antibodies against Aldh1a2 and
3 were developed. For the anti-Aldh1a2 antibody the peptide
GGKGLGRKGFFIEP was chosen. This peptide was synthesized by
PeptidoGenic (Livermore, California), conjugated to Imject Acti-
vated KLH (Pierce, Rockford, Illinois), and injected intradermally
into rabbits with Hunter’s Titermax Gold (CytRx Corp., Norcross,
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Georgia). Antiserum was first purified on a Protein A Sepharose
column (Pierce, Rockford, Illinois) to obtain an immunoglobulin (Ig)
G fraction. Then the IgG fraction was affinity purified using a
histidine-tagged whole protein rat Aldh1a2 (generous gift of Marcia
Newcomer, PhD Dept. Biol. Sci., LSU) immobilized on a CNBr-
activated Sepharose 4B column (Amersham Biosciences, Piscat-
away, New Jersey). The Aldh1a3 antibody was made by a similar
procedure except a recombinant whole rat protein was used for
the immunization and it was affinity purified using the recombinant
whole protein immobilized on a Sulfolink column (Pierce, Rockford,
Illinois).
Dot blot analysis Recombinant whole protein rat Aldh1a2 was a
generous gift of Marcia Newcomer, PhD Dept. Biol. Sci., LSU.
Histidine-tagged whole protein rat Aldh1a3 was expressed in
Escherichia coli and purified using Ni Agarose according to the
manufacturer’s instructions (Qiagen, Valencia, California). These
proteins (0–25 pmol) were blotted onto a nitrocellulose membrane
(BioRad, Hercules, California) using the Bio-Dot microfiltration
apparatus (BioRad) according to the manufactures instructions.
Strips of dots blots were cut and blocked with 5% dry milk in Tris
buffered saline containing 0.1% Tween. Blots were then incubated
in primary antibody for 1 h, washed with Tris buffered saline with
0.1% Tween, incubated with an antirabbit antibody conjugated
with horseradish peroxidase (Jackson ImmunoResearch Labora-
tories, Inc., West Grove, Pennsylvania), washed again and
detected with enhanced chemiluminescence (Amersham Bio-
sciences).
Immunohistochemistry Sections were pre-treated with 3% hy-
drogen peroxide, blocked with 3% BSA plus 1.28% normal goat
serum, incubated with the primary antibody overnight at 41C, then
incubated with a biotin conjugated secondary antibody, an
antibiotin IgG conjugated with horseradish peroxidase, and then
stained with AECþ (Dako, Carpinteria, California; Bucco et al,
1997). Hydrogen peroxide and BSA were obtained from Sigma
(St. Louis, Missouri). Normal goat serum, secondary, and tertiary
antibodies were obtained from Jackson ImmunoResearch Labora-
tories, Inc. (West Grove, Pennsylvania). All mouse work was
approved by The Jackson Laboratory Institutional Animal Care and
Use Committee.
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